Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT

Altamira Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Selling, General & Admin
3.213.713.684.022.984.07
Upgrade
Research & Development
3.863.62.411.833.23.41
Upgrade
Other Operating Expenses
-0.23-0.29-0.010-0.20.01
Upgrade
Operating Expenses
6.857.036.075.865.977.5
Upgrade
Operating Income
-6.85-7.03-6.07-5.86-5.97-7.5
Upgrade
Interest Expense
-0.58-1.23-0.98-0.02-0.15-0.03
Upgrade
Interest & Investment Income
0.310.360.120.0300.02
Upgrade
Earnings From Equity Investments
-0.28-0.05----
Upgrade
Currency Exchange Gain (Loss)
-0.55-0.53-0.330.05-0.38-0.23
Upgrade
Other Non Operating Income (Expenses)
0.04-0.20.490.01-2.790.69
Upgrade
EBT Excluding Unusual Items
-7.91-8.67-6.77-5.79-9.29-7.05
Upgrade
Asset Writedown
---13.41-1.68--
Upgrade
Other Unusual Items
00.03----
Upgrade
Pretax Income
-7.91-8.63-20.18-7.47-9.29-7.05
Upgrade
Income Tax Expense
---0.01-0.13-0.02-0.2
Upgrade
Earnings From Continuing Operations
-7.91-8.63-20.17-7.34-9.27-6.85
Upgrade
Earnings From Discontinued Operations
5.214.04-8.52-11.38--
Upgrade
Net Income
-2.7-4.59-28.69-18.71-9.27-6.85
Upgrade
Net Income to Common
-2.7-4.59-28.69-18.71-9.27-6.85
Upgrade
Shares Outstanding (Basic)
10000-
Upgrade
Shares Outstanding (Diluted)
10000-
Upgrade
Shares Change (YoY)
1503.64%978.83%37.51%120.26%--
Upgrade
EPS (Basic)
-1.91-9.35-630.04-565.06-616.45-
Upgrade
EPS (Diluted)
-1.91-9.35-630.04-565.06-616.45-
Upgrade
Free Cash Flow
-7.58-13.67-9.39-15-5.47-8.73
Upgrade
Free Cash Flow Per Share
-5.35-27.83-206.22-452.91-364.11-
Upgrade
EBITDA
---6.02-5.81-5.95-7.46
Upgrade
D&A For EBITDA
--0.050.050.020.03
Upgrade
EBIT
-6.85-7.03-6.07-5.86-5.97-7.5
Upgrade
Updated Sep 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.